Matrix effects present a significant challenge in the LC-MS/MS analysis of microbial secondary metabolites, potentially compromising the accuracy, precision, and sensitivity of quantitative methods essential for pharmaceutical and clinical research.
This article provides a comprehensive guide for researchers and drug development professionals facing challenges with low accuracy during microbiological method verification.
This article provides researchers, scientists, and drug development professionals with a comprehensive framework for verifying culture media, a critical component of reliable microbiological testing.
This article provides a comprehensive framework for resolving discrepant results encountered during the verification and validation of microbiological methods.
This article provides researchers, scientists, and drug development professionals with a comprehensive framework for the successful verification and implementation of Rapid Microbiological Methods (RMM).
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on the verification and validation of molecular methods in clinical microbiology.
This article provides a comprehensive guide to the CLSI M52 guideline for researchers, scientists, and drug development professionals involved in verifying commercial microbial identification (ID) and antimicrobial susceptibility testing (AST)...
This article provides a structured framework for developing and executing a robust method verification plan in clinical microbiology laboratories.
This article provides a comprehensive framework for verifying the reportable range of semi-quantitative microbiology tests, a critical requirement for clinical and research laboratories.
This article provides a comprehensive framework for establishing and verifying reference ranges during microbiological method verification, a critical process for ensuring test reliability in drug development and clinical diagnostics.